Showing results (141-150 of 212) with videos related to
Sort By:
Pageof 22
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trialJustin A Ezekowitz, Basil S Lewis, Renato D Lopes, et al.European Heart Journal. Imaging Methods and Practice|July 24, 2024
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditisPaul C Cremer, David Lin, Sushil A Luis, et al.American Heart Journal|February 16, 2018
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trialDavid Kopin, W Schuyler Jones, Matthew W Sherwood, et al.Circulation|April 8, 2018
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIERMarc S Sabatine, Gaetano M De Ferrari, Robert P Giugliano, et al.JAMA Cardiology|May 21, 2020
Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER TrialBaris Gencer, François Mach, Sabina A Murphy, et al.Journal of the American College of Cardiology|August 14, 2015
Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 TrialConnie N Hess, Stefan James, Renato D Lopes, et al.American Heart Journal|March 30, 2013
Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategyMarc W Klutstein, Cynthia M Westerhout, Paul W Armstrong, et al.Journal of the American Heart Association|March 12, 2024
Sustained Pericarditis Recurrence Risk Reduction With Long-Term RilonaceptMassimo Imazio, Allan L Klein, Antonio Brucato, et al.Lancet (London, England)|April 8, 2011
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trialSanjit S Jolly, Salim Yusuf, John Cairns, et al.American Heart Journal|June 23, 2014
Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAnna Kotsia, Emmanouil S Brilakis, Claes Held, et al.Pageof 22